"Hypogonadism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).
Descriptor ID |
D007006
|
MeSH Number(s) |
C19.391.482
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypogonadism".
Below are MeSH descriptors whose meaning is more specific than "Hypogonadism".
This graph shows the total number of publications written about "Hypogonadism" by people in this website by year, and whether "Hypogonadism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 2 | 0 | 2 |
2009 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypogonadism" by people in Profiles.
-
Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses. RMD Open. 2020 09; 6(2).
-
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study. Diabetes Care. 2019 06; 42(6):1104-1111.
-
Systemic sarcoidosis with hypercalcaemia, hypothalamic-pituitary dysfunction and thyroid involvement. BMJ Case Rep. 2016 Aug 05; 2016.
-
Persistent hypogonadism influences estradiol synthesis, cognition and outcome in males after severe TBI. Brain Inj. 2012; 26(10):1226-42.
-
Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. 2009 Jul; 15(4):289-305.
-
Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men. J Clin Endocrinol Metab. 2008 Mar; 93(3):944-50.
-
Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007 Feb; 117(2):457-63.
-
Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism. AJR Am J Roentgenol. 1998 Feb; 170(2):423-7.
-
Micropenis: medical and surgical implications. J Urol. 1994 Jul; 152(1):4-14.
-
Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol. 1979 Mar 01; 133(5):525-36.